Christopher F. Lowe - Concepedia

Author

Christopher F. Lowe

Also Known As

A Duku, C Lowe, C. F. Lowe, C. LOWE, C. Lowe, C.F. Lowe, Calvin Lowe, Chandler Lowe, Christian Lowe, Christopher F. Lowe

141

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia St. Paul's Hospital AIDS Vancouver Providence Health Care Simon Fraser University

About

Christopher F. Lowe is an author at University of British Columbia specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	879
2	Health Sciences	7	7	333
3	Public Health	3	3	240
4	Education	1	1	15
5	Management	1	1	15

Christopher F. Lowe

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Outbreak of Extended-Spectrum β-Lactamase–producing<i>Klebsiella oxytoca</i>Infections Associated with Contaminated Handwashing Sinks1 Christopher F. Lowe, Barbara Willey, Anna O’Shaughnessy, Emerging infectious diseases Pathogenic MicrobiologyKlebsiella PneumoniaeBacterial PathogensIntensive Care UnitAntimicrobial Stewardship	2012	174
Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force Valeria Fabre, Angelina Davis, Daniel J. Diekema, Infection Control and Hospital Epidemiology Point-of-care TestingDiagnosisDiagnostic StewardshipMedical DiagnosisDiagnostic Pathway	2023	122
Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results Natalie N. Kinloch, Gordon Ritchie, Chanson J. Brumme, The Journal of Infectious Diseases Molecular Diagnostic TechniquesViral DiagnosticsMedicineDiagnostic TestCovid-19 Pandemic	2020	105
Bedbugs as Vectors for Drug-Resistant Bacteria Christopher F. Lowe, Marc G. Romney Emerging infectious diseases Antimicrobial SusceptibilityMedicineZoonotic DiseaseEvolutionary BiologyEntomology	2011	57
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO) Peter Hall, Simon Lord, Michelle Collinson, British Journal of Cancer	2017	47
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, The Journal of Infectious Diseases	2022	46
Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals David Banach, Bree Johnston, Duha Al‐Zubeidi, Infection Control and Hospital Epidemiology	2017	45
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, The Journal of Infectious Diseases	2022	43
Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada Nancy Matic, Christopher F. Lowe, Gordon Ritchie, Emerging infectious diseases	2021	42
Antimicrobial stewardship for hospitalized patients with viral respiratory tract infections Christopher F. Lowe, Michael Payne, David Puddicombe, American Journal of Infection Control AntibioticsHealthcare-associated InfectionRespiratory InfectionInfectious Respiratory DiseaseInfection Control	2017	40

Page 1